104 related articles for article (PubMed ID: 25390539)
1. Migration of intravitreal dexamethasone implant to anterior chamber.
Gullapalli VK; DiLoreto DA
Retin Cases Brief Rep; 2013; 7(1):111-3. PubMed ID: 25390539
[TBL] [Abstract][Full Text] [Related]
2. Anterior Chamber Dislocation of Dexamethasone Implant in the Presence of Carlevale Sutureless Scleral Fixation Intraocular Lens.
Stavrakas P; Gartaganis P; Totou S; Chalkiadaki E; Manousakis E; Karmiris E
Case Rep Ophthalmol; 2023; 14(1):229-233. PubMed ID: 37383169
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
[TBL] [Abstract][Full Text] [Related]
4. The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).
Kang H; Lee MW; Byeon SH; Koh HJ; Lee SC; Kim M
Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1819-1825. PubMed ID: 28601910
[TBL] [Abstract][Full Text] [Related]
5. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.
Khurana RN; Appa SN; McCannel CA; Elman MJ; Wittenberg SE; Parks DJ; Ahmad S; Yeh S
Ophthalmology; 2014 Jan; 121(1):67-71. PubMed ID: 23890421
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for and management of anterior chamber intravitreal dexamethasone implant migration.
Röck D; Bartz-Schmidt KU; Röck T
BMC Ophthalmol; 2019 May; 19(1):120. PubMed ID: 31138164
[TBL] [Abstract][Full Text] [Related]
7. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.
Pacella F; Agostinelli E; Carlesimo SC; Nebbioso M; Secondi R; Forastiere M; Pacella E
J Med Case Rep; 2016 Oct; 10(1):282. PubMed ID: 27733187
[TBL] [Abstract][Full Text] [Related]
8. Surgical Management of Anterior Chamber Migration of a Dexamethasone Intravitreal Implant.
Stelton CR; Townsend J; Peterson LT; Khurana RN; Yeh S
Ophthalmic Surg Lasers Imaging Retina; 2015; 46(7):756-9. PubMed ID: 26247457
[TBL] [Abstract][Full Text] [Related]
9. [Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases].
Malclès A; Janin-Manificat H; Yhuel Y; Russo A; Agard E; El Chehab H; Ract Madoux G; Masse H; Burillon C; Dot C
J Fr Ophtalmol; 2013 Apr; 36(4):362-7. PubMed ID: 23318000
[TBL] [Abstract][Full Text] [Related]
10. [Anterior chamber migration of a dexamethasone implant in a pseudophakic patient with a scleral-fixated posterior chamber intraocular lens].
Laplace O; Rodallec T; Akesbi J; Sandali O
J Fr Ophtalmol; 2013 Apr; 36(4):e59-61. PubMed ID: 23433821
[TBL] [Abstract][Full Text] [Related]
11. [Pars plana vitrectomy and intravitreal triamcinolone for chronic pseudophakic cystoid macular edema].
Bencić G; Vatavuk Z; Mandić Z
Acta Med Croatica; 2006; 60(2):93-6. PubMed ID: 16848195
[TBL] [Abstract][Full Text] [Related]
12. Anterior chamber migration of a sustained-release dexamethasone intravitreal implant: A case report and review of literature.
Majumder PD; Palkar AH; Pathare N; Biswas J
Oman J Ophthalmol; 2019; 12(2):133-137. PubMed ID: 31198303
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
14. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone Implant Migration through an Iris Coloboma.
Glidai Y; Schwartz S; Cohen E
Case Rep Ophthalmol; 2020; 11(1):73-78. PubMed ID: 32110233
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM;
Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341
[TBL] [Abstract][Full Text] [Related]
17. Anterior migration of intravitreal fluocinolone acetonide (Iluvien®) implant in a pseudophakic eye with intact posterior capsule.
Alzaabi M; Taguri AH; Elbarky A
Am J Ophthalmol Case Rep; 2020 Dec; 20():100922. PubMed ID: 32995665
[TBL] [Abstract][Full Text] [Related]
18. Recalcitrant macular edema after intravitreal bevacizumab is responsive to an intravitreal dexamethasone implant in retinal vein occlusion.
Sharareh B; Gallemore R; Taban M; Onishi S; Wallsh J
Retina; 2013 Jun; 33(6):1227-31. PubMed ID: 23518900
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edema.
Sevim MS; Sanisoglu H; Turkyilmaz K
Curr Eye Res; 2012 Dec; 37(12):1165-70. PubMed ID: 22928501
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal triamcinolone acetonide: a change in a paradigm.
Jonas JB
Ophthalmic Res; 2006; 38(4):218-45. PubMed ID: 16763379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
